猴痘病毒感染与接种后体液免疫随时间衰减:加拿大2020至2023年研究
该回顾性观察研究追踪2022年全球猴痘疫情中46例感染者的86份血液样本至感染后7个月,发现IgM短暂出现、IgG在1-2个月达峰后持续下降;感染后接种MVA-BN疫苗未显著增强抗体反应,25名长期疫苗接种者30个月后对多数抗原血清阳性低至检测不到。
要点
- 猴痘感染后IgG抗体1-2个月达峰后持续下降,提示再感染风险。
- 感染后接种MVA-BN疫苗未显著提升抗体强度、广度或持久性。
- 长期疫苗接种者30个月后对多数MPXV抗原血清阳性低至检测不到。
核心结论
- 循环抗体滴度被视为猴痘保护相关指标,抗体水平下降提示既往感染和接种者易感性增加。
- 需进一步评估长期疫苗有效性以指导加强接种建议。
研究设计与样本
- 回顾性观察研究,纵向队列纳入2022年全球猴痘疫情期间46例MPXV感染者,采集86份血液样本至感染后7个月。
- 另用25名未感染长期MVA-BN疫苗接种者独立队列分析抗体应答。
- 采用针对8种病毒抗原的血清学检测分析抗体反应。
主要发现
- 感染后最初数周出现短暂IgM应答,IgG多克隆应答在感染后1-2个月达峰但在随后数月持续下降。
- 感染后接种第三代MVA-BN疫苗未显著增加抗体应答的强度、广度或持久性。
- 25名未感染长期MVA-BN疫苗接种者30个月后对多数MPXV抗原血清阳性低至检测不到。
临床怎么用
- 监测既往感染者和接种者的抗体衰减,评估再感染或突破感染风险。
- 现有证据提示需进一步研究长期疫苗有效性以制定加强接种策略。
局限性
- 回顾性观察设计,样本量有限(感染者46例,长期疫苗接种者25例)。
- 随访至感染后7个月,长期疫苗队列观察30个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDMonkeypox virus (MPXV) has spread globally to non-endemic countries in recent years and has the potential to cause recurrent outbreaks. Vaccine breakthrough infections and reinfections are suggested to be linked to immunity waning over time.AIMWe aimed to determine how long individuals remain protected following MPXV infection and if vaccination can be used as a public heath measure to elicit durable protective immune responses.METHODSThis retrospective observational study investigated the durability of humoral immune responses in a longitudinal cohort of 46 individuals infected with MPXV during the 2022 global mpox outbreak. We collected 86 blood samples up to 7 months after infection, and analysed the antibody responses against MPXV with a serological assay using a panel of eight viral antigens.RESULTSMonitoring of antibody kinetics revealed transient IgM responses in the first weeks following infection and a robust polyclonal IgG response that peaked 1-2 months after infection but declined consistently in the following months. Post-exposure immunisation with third-generation modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine did not seem to increase significantly the strength, breadth or longevity of antibody responses. Using a separate cohort of 25 uninfected long-term MVA-BN vaccinees, we observed low to undetectable seropositivity against most MPXV antigens after 30 months.CONCLUSIONAs circulating antibody titres have been identified as a correlate of protection against mpox, declining antibody levels raise concerns for mpox susceptibility in previously infected and vaccinated persons. This warrants further evaluation of long-term vaccine effectiveness to inform booster vaccination guidance.
引用
- Prévost J, Medina SJ, Márquez AC, et al. Waning humoral immunity following monkeypox virus infection and vaccination, Canada, 2020 to 2023. Euro Surveill. 2026. PMID: 42141880. doi:10.2807/1560-7917.ES.2026.31.14.2500479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。